Clinical Development, Medical Affairs
Bartholomew J. Tortella is a medical professional with extensive experience in rare disease management, particularly in hemophilia, sickle cell disease, and critical bleeding. He has held various leadership positions in pharmaceutical companies like Pfizer, Spark Therapeutics (Roche), and Novo Nordisk, managing medical affairs, clinical trials, and development teams. Dr. Tortella has worked closely with patient advocacy organizations and medical societies and has served on FDA Advisory Committees.
Expertise
- Rare disease management across clinical practice and business
- Managing clinical trial operations for multiple rare disease studies
- Diverse education background, including MD from Harvard Medical School, MBA from Columbia University School of Business, an MTS (Ethics) from Harvard Divinity School, and a bachelor’s in science degree in Biology (summa cum laude) from St. Joseph’s University
Experience
- Served as a trauma surgeon and critical care physician for more than three decades
- Led medical affairs and real-world evidence teams in pharmaceutical industry
- His multifaceted expertise and dedication to advancing medical science have earned him recognition and accolades throughout his career.